New psoriasis drug shows promise in early trial
NCT ID NCT01585233
First seen Nov 17, 2025 · Last updated May 07, 2026 · Updated 20 times
Summary
This study tested a new drug called ASKP1240 in 60 people with moderate to severe plaque psoriasis. The goal was to see if the drug is safe and how it works in the body compared to a placebo. Participants received multiple doses, and researchers measured drug levels, immune system effects, and changes in psoriasis severity over 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Auckland Clinical Studies
Auckland, 1010, New Zealand
-
CMAX
Adelaide, Victoria, 5000, Australia
-
Christchurch Clincial Studies Trust, Ltd.
Christchurch, 8011, New Zealand
-
Durondel C.P. Inc, The Dermatology Clinic
Moncton, New Brunswick, E1C 8X3, Canada
-
Epworth Hospital
Richmond, Victoria, 3121, Australia
-
Innovaderm Research, Inc.
Montreal, Quebec, H2K 4L5, Canada
-
K. Papp Clinical Research
Waterloo, Ontario, N2J 1C4, Canada
-
Linear Research
Nedlands, Western Australia, 6009, Australia
-
New Lab Clinical Research
St. John's, Newfoundland and Labrador, A1C 2H5, Canada
-
P3 Research, Tauranga
Tauranga, 3110, New Zealand
-
P3 Research, Wellington
Wellington, 6021, New Zealand
-
Specialist Connect
Brisbane, Queensland, 4102, Australia
-
Ultranova Skincare
Barrie, Ontario, L4M 6L2, Canada
Conditions
Explore the condition pages connected to this study.